Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 8093

1.

The mTOR signalling cascade: paving new roads to cure neurological disease.

Crino PB.

Nat Rev Neurol. 2016 Jun 24. doi: 10.1038/nrneurol.2016.81. [Epub ahead of print] Review.

PMID:
27340022
2.

Our experience of carbon dioxide laser ablation of angiofibromas: case series and literature review.

Ali FR, Mallipeddi R, Craythorne EE, Sheth N, Al-Niaimi F.

J Cosmet Laser Ther. 2016 Jun 22:1-11. [Epub ahead of print]

PMID:
27331628
3.

Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis.

Moavero R, Marciano S, Graziola F, Curatolo P.

Epilepsy Behav Case Rep. 2016 Jan 13;5:13-6. doi: 10.1016/j.ebcr.2015.12.001. eCollection 2016.

4.

Therapeutic Strategies for Hereditary Kidney Cancer.

Sidana A, Srinivasan R.

Curr Oncol Rep. 2016 Aug;18(8):50. doi: 10.1007/s11912-016-0537-6. Review.

PMID:
27325049
5.

How common is tuberous sclerosis complex?

Morrison PJ, Donnelly DE.

Br J Dermatol. 2016 Jun;174(6):1184-5. doi: 10.1111/bjd.14592. No abstract available.

PMID:
27317279
6.
7.
8.

YAP enters the mTOR pathway to promote tuberous sclerosis complex.

Liang N, Pende M.

Mol Cell Oncol. 2015 May 1;2(4):e998100. doi: 10.1080/23723556.2014.998100. eCollection 2015 Oct-Dec.

9.

Tuberous sclerosis complex: A case report.

Sarkar S, Khaitan T, Sinha R, Kabiraj A.

Contemp Clin Dent. 2016 Apr-Jun;7(2):236-9. doi: 10.4103/0976-237X.183071.

10.

Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.

Mühlebner A, van Scheppingen J, Hulshof HM, Scholl T, Iyer AM, Anink JJ, van den Ouweland AM, Nellist MD, Jansen FE, Spliet WG, Krsek P, Benova B, Zamecnik J, Crino PB, Prayer D, Czech T, Wöhrer A, Rahimi J, Höftberger R, Hainfellner JA, Feucht M, Aronica E.

PLoS One. 2016 Jun 13;11(6):e0157396. doi: 10.1371/journal.pone.0157396. eCollection 2016.

11.

Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.

Yue M, Pacheco G, Cheng T, Li J, Wang Y, Henske EP, Schuger L.

Am J Pathol. 2016 Jul;186(7):1825-36. doi: 10.1016/j.ajpath.2016.03.009. Epub 2016 Jun 8.

PMID:
27289491
12.

Multi-compartment microscopic diffusion imaging.

Kaden E, Kelm ND, Carson RP, Does MD, Alexander DC.

Neuroimage. 2016 Jun 6. pii: S1053-8119(16)30206-3. doi: 10.1016/j.neuroimage.2016.06.002. [Epub ahead of print]

13.

Koenen's tumor and facial angiofibromas in a case of Birt-Hogg-Dubé syndrome: A cutaneous contribution to growing evidence of a relationship with tuberous sclerosis complex.

DiCicco B, Johnson W, Allred J, Soldano AC, Ramsdell WM.

JAAD Case Rep. 2016 May 25;2(3):196-8. doi: 10.1016/j.jdcr.2016.03.014. eCollection 2016 May. No abstract available.

14.

Sestrin regulation of TORC1: Is Sestrin a leucine sensor?

Lee JH, Cho US, Karin M.

Sci Signal. 2016 Jun 7;9(431):re5. doi: 10.1126/scisignal.aaf2885. Review.

PMID:
27273098
15.

Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference.

Sahin M, Henske EP, Manning BD, Ess KC, Bissler JJ, Klann E, Kwiatkowski DJ, Roberds SL, Silva AJ, Hillaire-Clarke CS, Young LR, Zervas M, Mamounas LA; Tuberous Sclerosis Complex Working Group to Update the Research Plan.

Pediatr Neurol. 2016 Apr 2. pii: S0887-8994(16)30167-9. doi: 10.1016/j.pediatrneurol.2016.03.015. [Epub ahead of print] Review.

PMID:
27267556
16.

The economic burden of tuberous sclerosis complex in the UK: A retrospective cohort study in the Clinical Practice Research Datalink.

Kingswood JC, Crawford P, Johnson SR, Sampson JR, Shepherd C, Demuth D, Erhard C, Nasuti P, Patel K, Myland M, Pinnegar A, Magestro M, Gray E.

J Med Econ. 2016 Jun 22:1-12. [Epub ahead of print]

PMID:
27267148
17.

Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex.

Zhang B, Zou J, Han L, Rensing N, Wong M.

Epilepsia. 2016 Jun 6. doi: 10.1111/epi.13429. [Epub ahead of print]

PMID:
27263494
18.

mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus.

Schneider M, de Vries PJ, Schönig K, Rößner V, Waltereit R.

Eur Arch Psychiatry Clin Neurosci. 2016 Jun 4. [Epub ahead of print]

PMID:
27263037
19.

Formulation and characterization of a 0.1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas.

Bouguéon G, Lagarce F, Martin L, Pailhoriès H, Bastiat G, Vrignaud S.

Int J Pharm. 2016 Jun 1;509(1-2):279-284. doi: 10.1016/j.ijpharm.2016.05.064. [Epub ahead of print]

PMID:
27260135
20.

Roles for Astrocytes in Epilepsy: Insights from Malformations of Cortical Development.

Kielbinski M, Gzielo-Jurek K, Soltys Z.

Neuropathol Appl Neurobiol. 2016 Jun 3. doi: 10.1111/nan.12331. [Epub ahead of print] Review.

PMID:
27257021
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk